The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
The pathogenic role of angiogenesis in rheumatoid arthritis
Open accessAbstract
Angiogenesis is the formation of new capillaries from pre-existing vasculature, which plays a critical role in the pathogenesis of several inflammatory autoimmune diseases such as rheumatoid arthritis (RA), spondyloarthropathies, psoriasis, systemic lupus erythematosus, systemic sclerosis, and atherosclerosis. In RA, excessive migration of circulating leukocytes into the inflamed joint necessitates formation of new blood vessels to provide nutrients and oxygen to the hypertrophic joint. The dominance of the pro-angiogenic factors over the endogenous angiostatic mediators triggers angiogenesis. In this review article, we highlight the underlying mechanisms by which cells present in the RA synovial tissue are modulated to secrete pro-angiogenic factors. We focus on the significance of pro-angiogenic factors such as growth factors, hypoxia-inducible factors, cytokines, chemokines, matrix metalloproteinases, and adhesion molecules on RA pathogenesis. As pro-angiogenic factors are primarily produced from RA synovial tissue macrophages and fibroblasts, we emphasize the key role of RA synovial tissue lining layer in maintaining synovitis through neovascularization. Lastly, we summarize the specific approaches utilized to target angiogenesis. We conclude that the formation of new blood vessels plays an indispensable role in RA progression. However, since the function of several pro-angiogenic mediators is cross regulated, discovering novel approaches to target multiple cascades or selecting an upstream cascade that impairs the activity of a number of pro-angiogenic factors may provide a promising strategy for RA therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“M1 macrophages express cell surface markers such as CCR7, CD215, CD80 and CD86, and secrete TNF, IL-6, IL-1b, CCL2, IL-8, IL-12, and IL-23 upon activation with interferon (IFN)c, lipopolysaccharides (LPS) or granulocyte–macrophage colony-stimulating factor (GM-CSF) [32–34].”
BackgroundFolkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Schulz, C., Perdiguero, E. G., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E. W., Pollard, J. W., et al. (2012) · Science · doi:10.1126/science.1219179 · Cited by 2,578
Interleukin-8 as a macrophage-derived mediator of angiogenesis
Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., & Strieter, R. M. (1992) · Science · doi:10.1126/science.1281554 · Cited by 2,135 · cited 1×
“Results from earlier studies show that IL-8, like TNF, can directly trigger RA angiogenesis by binding to its corresponding receptors CXCR1 and CXCR2 on endothelial cells, and neutralization of IL-8 reduced the angiogenic activity of synovial tissue macrophage-conditioned media [81].”
BackgroundDavies, L. C., Jenkins, S. J., Allen, J. E., & Taylor, P. R. (2013) · Nature Immunology · doi:10.1038/ni.2705 · Cited by 2,096
HIF-1α is essential for myeloid cell-mediated inflammation
Cramer, T., Yamanishi, Y., Clausen, B. E., Förster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00154-5 · Cited by 2,046
Bevilacqua, M. P., Stengelin, S., Gimbrone, M. A., & Seed, B. (1989) · Science · doi:10.1126/science.2466335 · Cited by 2,005
the Immunological Genome Consortium, Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2419 · Cited by 1,972 · cited 1×
“Tissue-resident macrophages originate primarily from embryonic progenitors and to less extent from circulating monocyte intermediates, and additionally, many of them are capable of self-renewing [22–25].”
BackgroundFibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
Bartok, B., & Firestein, G. S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00859.x · Cited by 1,906
Interleukin-6 and chronic inflammation.
Gabay, C. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1917 · Cited by 1,692
Origin and functions of tissue macrophages
Epelman, S., Lavine, K. J., & Randolph, G. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.013 · Cited by 1,585 · cited 1×
“These cells are characterized by the high surface expression of Ly6C, CCR2 and CD11b, and low/absence of tissue-resident macrophages markers CD64, MerTK, and CD14 [24–29].”
BackgroundThe chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,525
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T., Feldmann, M., & Udalova, I. A. (2011) · Nature Immunology · doi:10.1038/ni.1990 · Cited by 1,306
Matrix Metalloproteinases: Role In Arthritis
Burrage, P. (2006) · Frontiers in Bioscience · doi:10.2741/1817 · Cited by 1,292
Vascular Endothelial Growth Factor
Ferrara, N. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179663 · Cited by 1,283
Selectins: Interpreters of Cell-Specific Carbohydrate Information During Inflammation
Lasky, L. A. (1992) · Science · doi:10.1126/science.1439808 · Cited by 1,236
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α
Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., & Nuseir, N. (1987) · Nature · doi:10.1038/329630a0 · Cited by 1,210
MIF as a glucocorticoid-induced modulator of cytokine production
Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T., Cerami, A., & Bucala, R. (1995) · Nature · doi:10.1038/377068a0 · Cited by 1,149
Matrix metalloproteinases: a tail of a frog that became a prince
Brinckerhoff, C. E., & Matrisian, L. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm763 · Cited by 1,105
Calandra, T., Bernhagen, J., Mitchell, R. A., & Bucala, R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.6.1895 · Cited by 985
Bain, C. C., Scott, C. L., Uronen-Hansson, H., Gudjonsson, S., Jansson, O., Grip, O., Guilliams, M., Malissen, B., Agace, W. W., & Mowat, A. M. (2013) · Mucosal Immunology · doi:10.1038/mi.2012.89 · Cited by 943
Vincenti, M. P., & Brinckerhoff, C. E. (2002) · Arthritis Research & Therapy · doi:10.1186/ar401 · Cited by 796
Folkman, J., & Shing, Y. (1992) · PubMed · Cited by 789
Jakubzick, C., Gautier, E. L., Gibbings, S. L., Sojka, D. K., Schlitzer, A., Johnson, T. E., Ivanov, S., Duan, Q., Bala, S., Condon, T., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.007 · Cited by 783
Lubberts, E., Koenders, M. I., Oppers‐Walgreen, B., van den Bersselaar, L., Coenen‐de Roo, C. J. J., Joosten, L. A. B., & van den Berg, W. B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20001 · Cited by 709
A proinflammatory role for IL-18 in rheumatoid arthritis
Gracie, J. A., Forsey, R. J., Chan, W. L., Gilmour, A., Leung, B. P., Greer, M. R., Kennedy, K., Carter, R., Wei, X.-Q., Xu, D., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7317 · Cited by 636
Synovial fibroblasts: key players in rheumatoid arthritis
Huber, L. C., Distler, O., Tarner, I., Gay, R. E., Gay, S., & Pap, T. (2006) · Rheumatology · doi:10.1093/rheumatology/kel065 · Cited by 607
Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
Koch, A. E., Halloran, M. M., Haskell, C. J., Shah, M. R., & Polverini, P. J. (1995) · Nature · doi:10.1038/376517a0 · Cited by 600
Firestein, G. S. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391103 · Cited by 591
Koch, A. E., Harlow, L. A., Haines, G. K., Amento, E. P., Unemori, E. N., Wong, W. L., Pope, R. M., & Ferrara, N. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.8.4149 · Cited by 575
Salcedo, R., Wasserman, K., Young, H. A., Grimm, M. C., Howard, O. M. Z., Anver, M. R., Kleinman, H. K., Murphy, W. J., & Oppenheim, J. J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65365-5 · Cited by 540
Tamoutounour, S., Henri, S., Lelouard, H., de Bovis, B., de Haar, C., van der Woude, C. J., Woltman, A. M., Reyal, Y., Bonnet, D., Sichien, D., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201242847 · Cited by 525
Fava, R. A., Olsen, N. J., Spencer-Green, G., Yeo, K. T., Yeo, T. K., Berse, B., Jackman, R. W., Senger, D. R., Dvorak, H. F., & Brown, L. F. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.341 · Cited by 520
Synovial tissue macrophage populations and articular damage in rheumatoid arthritis
Mulherin, D., Fitzgerald, O., & Bresnihan, B. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390116 · Cited by 515
Inflammation: Basic Principles and Clinical Correlates
Ehrlich, G. E. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500240106040 · Cited by 505
Angiogenesis: Implications for rheumatoid arthritis
Koch, A. E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199806)41:6<951::aid-art2>3.0.co;2-d · Cited by 504
Nakae, S., Saijo, S., Horai, R., Sudo, K., Mori, S., & Iwakura, Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1035999100 · Cited by 490
Haringman, J. J., Gerlag, D. M., Zwinderman, A. H., Smeets, T. J. M., Kraan, M. C., Baeten, D., McInnes, I. B., Bresnihan, B., & Tak, P. P. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.029751 · Cited by 457
Up‐regulation of cytokines and chemokines predates the onset of rheumatoid arthritis
Kokkonen, H., Söderström, I., Rocklöv, J., Hallmans, G., Lejon, K., & Rantapää Dahlqvist, S. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27186 · Cited by 454
Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome
Donnelly, S. C., Haslett, C., Reid, P. T., Grant, I. S., Wallace, W. A. H., Metz, C. N., Bruce, L. J., & Bucala, R. (1997) · Nature Medicine · doi:10.1038/nm0397-320 · Cited by 449
Koshiba, T., Hosotani, R., Miyamoto, Y., Ida, J., Tsuji, S., Nakajima, S., Kawaguchi, M., Kobayashi, H., Doi, R., Hori, T., et al. (2000) · PubMed · Cited by 424
Angiogenesis and angiogenesis inhibition: An overview
Folkman, J. (1997) · Experientia Supplementum · doi:10.1007/978-3-0348-9006-9_1 · Cited by 410
Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Mease, P. J., Genovese, M. C., Greenwald, M. W., Ritchlin, C. T., Beaulieu, A. D., Deodhar, A., Newmark, R., Feng, J., Erondu, N., & Nirula, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315231 · Cited by 395
Nakahara, H., Song, J., Sugimoto, M., Hagihara, K., Kishimoto, T., Yoshizaki, K., & Nishimoto, N. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11143 · Cited by 395
Rheumatoid arthritis progression mediated by activated synovial fibroblasts
Neumann, E., Lefèvre, S., Zimmermann, B., Gay, S., & Müller-Ladner, U. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.004 · Cited by 394
Efalizumab for Patients With Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial
Gordon, K. B., Papp, K. A., Hamilton, T. K., Walicke, P. A., Dummer, W., Li, N., Bresnahan, B. W., Menter, A., & for the Efalizumab Study Group (2003) · JAMA · doi:10.1001/jama.290.23.3073 · Cited by 391
Rempel, S. A., Dudas, S., Ge, S., & Gutierrez, J. A. (2000) · PubMed · Cited by 364
Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritis
Konisti, S., Kiriakidis, S., & Paleolog, E. M. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.205 · Cited by 335
Mills, C. D. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.8.2719 · Cited by 333
Angiogenesis inhibition: A review
Auerbach, W., & Auerbach, R. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90027-2 · Cited by 321
Matrix metalloproteinases in arthritic disease.
Murphy, G., Knäuper, V., Atkinson, S. J., Butler, G., English, W., Hutton, M., Stracke, J. O., & Clark, I. M. (2002) · Arthritis Research · doi:10.1186/ar572 · Cited by 313
Leech, M., Metz, C., Hall, P., Hutchinson, P., Gianis, K., Smith, M., Weedon, H., Holdsworth, S. R., Bucala, R., & Morand, E. F. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199908)42:8<1601::aid-anr6>3.0.co;2-b · Cited by 311
Macrophages and their products in rheumatoid arthritis
Szekanecz, Z., & Koch, A. E. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32805e87ae · Cited by 308
Synovial tissue macrophage as a source of the chemotactic cytokine IL-8
Koch, A. E., Kunkel, S. L., Burrows, J. C., Evanoff, H. L., Haines, G. K., Pope, R. M., & Strieter, R. M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.7.2187 · Cited by 298
Genovese, M. C., Durez, P., Richards, H. B., Supronik, J., Dokoupilova, E., Mazurov, V., Aelion, J. A., Lee, S.-H., Codding, C. E., Kellner, H., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201601 · Cited by 293
Katschke, K. J., Rottman, J. B., Ruth, J. H., Qin, S., Wu, L., LaRosa, G., Ponath, P., Park, C. C., Pope, R. M., & Koch, A. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1022::aid-anr181>3.0.co;2-n · Cited by 286
Expression of matrix metalloproteinase 9 (96‐kd gelatinase B) in human rheumatoid arthritis
Ahrens, D., Koch, A. E., Pope, R. M., Stein‐Picarella, M., & Niedbala, M. J. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390919 · Cited by 284
Mitroulis, I., Alexaki, V. I., Kourtzelis, I., Ziogas, A., Hajishengallis, G., & Chavakis, T. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.008 · Cited by 283
Evidence of IL-18 as a Novel Angiogenic Mediator
Park, C. C., Morel, J. C. M., Amin, M. A., Connors, M. A., Harlow, L. A., & Koch, A. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1644 · Cited by 263
Kavanaugh, A. F., Davis, L. S., Nichols, L. A., Norris, S. H., Rothlein, R., Scharschmidt, L. A., & Lipsky, P. E. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370703 · Cited by 263
Mehta, V. B., Hart, J., & Wewers, M. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006814200 · Cited by 255
Onodera, S., Kaneda, K., Mizue, Y., Koyama, Y., Fujinaga, M., & Nishihira, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.444 · Cited by 253
Matthys, P., Hatse, S., Vermeire, K., Wuyts, A., Bridger, G., Henson, G. W., De Clercq, E., Billiau, A., & Schols, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4686 · Cited by 251
Angiopoietins, growth factors, and vascular morphology in early arthritis.
Fearon, U., Griosios, K., Fraser, A. D., Reece, R., Emery, P., Jones, P. F., & Veale, D. J. (2003) · PubMed · Cited by 245
Mechanisms of Disease: angiogenesis in inflammatory diseases
Szekanecz, Z., & Koch, A. E. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0647 · Cited by 239
Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis
Ruth, J. H., Volin, M. V., Haines, G. K., Woodruff, D. C., Katschke, K. J., Woods, J. M., Park, C. C., Morel, J. C. M., & Koch, A. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1568::aid-art280>3.0.co;2-1 · Cited by 238
Self-citationDaly, C., Eichten, A., Castanaro, C., Pasnikowski, E., Adler, A., Lalani, A. S., Papadopoulos, N., Kyle, A. H., Minchinton, A. I., Yancopoulos, G. D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2064 · Cited by 230
Chen, D.-Y., Chen, Y.-M., Chen, H.-H., Hsieh, C.-W., Lin, C.-C., & Lan, J.-L. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3431 · Cited by 216
TH-17 cells in rheumatoid arthritis
Shahrara, S., Huang, Q., Mandelin, A. M., & Pope, R. M. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2477 · Cited by 216
Self-citationGenovese, M. C., Greenwald, M., Cho, C., Berman, A., Jin, L., Cameron, G. S., Benichou, O., Xie, L., Braun, D., Berclaz, P., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38617 · Cited by 211 · cited 1×
“Ixekizumab and secukinumab are both monoclonal neutralizing anti-IL-17 antibodies that can significantly reduce RA serum CRP levels and DAS28 scores and are currently being evaluated in phase II and III clinical trials [166, 167].”
BackgroundKuhne, M. R., Mulvey, T., Belanger, B., Chen, S., Pan, C., Chong, C., Cao, F., Niekro, W., Kempe, T., Henning, K. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2333 · Cited by 211
Marrelli, A., Cipriani, P., Liakouli, V., Carubbi, F., Perricone, C., Perricone, R., & Giacomelli, R. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.04.020 · Cited by 205
Adhesion molecules in autoimmune disease
McMurray, R. W. (1996) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(96)80034-5 · Cited by 197
Identification of transcriptional regulators in the mouse immune system
the Immunological Genome Project Consortium, Jojic, V., Shay, T., Sylvia, K., Zuk, O., Sun, X., Kang, J., Regev, A., & Koller, D. (2013) · Nature Immunology · doi:10.1038/ni.2587 · Cited by 194
Increased macrophage activation mediated through toll‐like receptors in rheumatoid arthritis
Huang, Q., Ma, Y., Adebayo, A., & Pope, R. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22707 · Cited by 193
Amin, M. A., Volpert, O. V., Woods, J. M., Kumar, P., Harlow, L. A., & Koch, A. E. (2003) · Circulation Research · doi:10.1161/01.res.0000087641.56024.da · Cited by 192
IL-17 Contributes to Angiogenesis in Rheumatoid Arthritis
Pickens, S. R., Volin, M. V., Mandelin, A. M., Kolls, J. K., Pope, R. M., & Shahrara, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903271 · Cited by 186
Self-citationFreemont, A. J., Hampson, V, Tilman, R., Goupille, P., Taiwo, Y., & Hoyland, J. A. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.9.542 · Cited by 184
Vascular involvement in rheumatic diseases: 'vascular rheumatology'
Szekanecz, Z., & Koch, A. E. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2515 · Cited by 183
Pablos, J. L., Santiago, B., Galindo, M., Torres, C., Brehmer, M. T., Blanco, F. J., & García-Lázaro, F. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2147 · Cited by 182
Garcia, G. E., Xia, Y., Chen, S., Wang, Y., Ye, R. D., Harrison, J. K., Bacon, K. B., Zerwes, H.-G., & Feng, L. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.4.577 · Cited by 179
Dormán, G., Cseh, S., Hajdú, I., Barna, L., Kónya, D., Kupai, K., Kovács, L., & Ferdinandy, P. (2010) · Drugs · doi:10.2165/11318390-000000000-00000 · Cited by 178
Lubberts, E. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0189-9 · Cited by 173
Fractalkine: A Novel Angiogenic Chemokine in Rheumatoid Arthritis
Volin, M. V., Woods, J. M., Amin, M. A., Connors, M. A., Harlow, L. A., & Koch, A. E. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62537-0 · Cited by 169
Self-citationSzekanecz, Z., & Koch, A. E. (2001) · Current Opinion in Rheumatology · doi:10.1097/00002281-200105000-00009 · Cited by 169
Role of cytokines, acute-phase proteins, and chemokinesin the progression of rheumatoid arthritis
Badolato, R., & Oppenheim, J. J. (1996) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(96)80041-2 · Cited by 161
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis
Leech, M. T., Metz, C. N., Santos, L. L., Peng, T., Holdsworth, S. R., Bucala, R., & Morand, E. F. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199805)41:5<910::aid-art19>3.0.co;2-e · Cited by 158
Coxon, A., BREADY, J. V., Min, H., Kaufman, S., Leal, J., Yu, D., Lee, T. A., Sun, J.-R., Estrada, J., Bolon, B. N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0213 · Cited by 158
Koch, A. E., & Distler, O. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2187 · Cited by 157
Chemokines and chemokine receptors in arthritis
Szekanecz, Z., Végvári, A., Szabo, Z., & Koch, A. E. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s53 · Cited by 156
Adhesion molecules. A rheumatologic perspective
Mojcik, C. F., & Shevach, E. M. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400602 · Cited by 151
Vascular Endothelial Growth Factor Expression and Regulation of Murine Collagen-Induced Arthritis
Lu, J., Kasama, T., Kobayashi, K., Yoda, Y., Shiozawa, F., Hanyuda, M., Negishi, M., Ide, H., & Adachi, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5922 · Cited by 146
Differential expression pattern of membrane‐type matrix metalloproteinases in rheumatoid arthritis
Pap, T., Shigeyama, Y., Kuchen, S., Fernihough, J. K., Simmen, B. R., Gay, R. E., Billingham, M. E. J., & Gay, S. (2000) · Arthritis & Rheumatism · Cited by 141
Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts
Honorati, M. C., Neri, S., Cattini, L., & Facchini, A. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.10.004 · Cited by 137
Cournia, Z., Leng, L., Gandavadi, S., Du, X., Bucala, R., & Jorgensen, W. L. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801100v · Cited by 135
Characterization of CCL19 and CCL21 in rheumatoid arthritis
Pickens, S. R., Chamberlain, N. D., Volin, M. V., Pope, R. M., Mandelin, A. M., & Shahrara, S. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30232 · Cited by 134
Self-citationOgawa, H., Nishihira, J., Sato, Y., Kondo, M., Takahashi, N., Oshima, T., & Todo, S. (2000) · Cytokine · doi:10.1006/cyto.1999.0562 · Cited by 132
Nishihira, J., Koyama, Y., & Mizue, Y. (1998) · Cytokine · doi:10.1006/cyto.1997.0276 · Cited by 131
Kavanaugh, A. F., Davis, L. S., Jain, R. I., Nichols, L. A., Norris, S. H., & Lipsky, P. E. (1996) · PubMed · Cited by 127
Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis
Akhavani, M., Madden, L., Buysschaert, I., Sivakumar, B., Kang, N., & Paleolog, E. M. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2689 · Cited by 125
Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis
Lainer, D. T., & Brahn, E. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0559 · Cited by 123
Hu, F., Mu, R., Zhu, J., Shi, L., Li, Y., Liu, X., Shao, W., Li, G., Li, M., Su, Y., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202444 · Cited by 122
Blades, M. C., Ingegnoli, F., Wheller, S. K., Manzo, A., Wahid, S., Panayi, G. S., Perretti, M., & Pitzalis, C. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10102 · Cited by 121
Natalizumab for relapsing remitting multiple sclerosis
Pucci, E., Giuliani, G., Solari, A., Simi, S., Minozzi, S., Pietrantonj, C. D., & Galea, I. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007621.pub2 · Cited by 120
Shahrara, S., Volin, M. V., Connors, M. A., Haines, G. K., & Koch, A. E. (2002) · Arthritis Research & Therapy · doi:10.1186/ar407 · Cited by 115
Self-citationMarkham, T., Mullan, R. H., Golden‐Mason, L., Rogers, S. C. F., Bresnihan, B., FitzGerald, O., Fearon, U., & Veale, D. J. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.01.038 · Cited by 115
Amelioration of rat adjuvant‐induced arthritis by Met‐RANTES
Shahrara, S., Proudfoot, A. E. I., Woods, J. M., Ruth, J. H., Amin, M. A., Park, C. C., Haas, C. S., Pope, R. M., Haines, G. K., Zha, Y. Y., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21033 · Cited by 115
Self-citationNF‐κB ‐inducing kinase is a key regulator of inflammation‐induced and tumour‐associated angiogenesis
Noort, A. R., van Zoest, K. P. M., Weijers, E. M., Koolwijk, P., Maracle, C. X., Novack, D. V., Siemerink, M. J., Schlingemann, R. O., Tak, P. P., & Tas, S. W. (2014) · The Journal of Pathology · doi:10.1002/path.4403 · Cited by 114
Macrophages in rheumatoid arthritis.
Maruotti, N., Cantatore, F. P., Crivellato, E., Vacca, A., & Ribatti, D. (2007) · PubMed · doi:10.14670/hh-22.581 · Cited by 111
Ruth, J. H., Haas, C. S., Park, C. C., Amin, M. A., Martinez, R. J., Haines, G. K., Shahrara, S., Campbell, P. L., & Koch, A. E. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21662 · Cited by 111
Self-citationKim, K. S., Choi, H. M., Lee, Y.-A., Choi, I. A., Lee, S., Hong, S., Yang, H.-I., & Yoo, M. C. (2010) · Rheumatology International · doi:10.1007/s00296-010-1592-1 · Cited by 108
Tocilizumab in the treatment of rheumatoid arthritis and beyond
Shetty, A., Hanson, R. L., Korsten, P., Shawagfeh, M., Arami, S., Volkov, S., Vila, O. M., Swedler, W., Shunaigat, A. N., Smadi, S., et al. (2014) · Drug Design, Development and Therapy · doi:10.2147/dddt.s41437 · Cited by 108
Self-citationInhibition of Monocyte Chemoattractant Protein-1 Ameliorates Rat Adjuvant-Induced Arthritis1
Shahrara, S., Proudfoot, A., Park, C. C., Volin, M., Haines, G., Woods, J., Aikens, C. H., Handel, T., & Pope, R. (2008) · Journal of Immunology · doi:10.4049/jimmunol.180.5.3447 · Cited by 106
Self-citationCho, M., Ju, J., Kim, H., Oh, H.-J., Kang, C., Jhun, J., Lee, S.-Y., Park, M., Min, J., Park, S., et al. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.11.005 · Cited by 105
Brouwer, E., Gouw, A. S. H., Posthumus, M. D., Leeuwen, M. A. V., Boerboom, A. L., Bijzet, J., Bos, R., Limburg, P. C., Kallenberg, C. G. M., & Westra, J. (2009) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 102
Gravallese, E. M., Pettit, A. R., Lee, R., Madore, R., Manning, C., Tsay, A., Gaspar, J., Goldring, M. B., Goldring, S. R., & Oettgen, P. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.2.100 · Cited by 98
Kavanaugh, A. F., Schulze‐Koops, H., Davis, L. S., & Lipsky, P. E. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400511 · Cited by 97
Yoo, J. K., Kwon, H., Khil, L.-Y., Zhang, L., Jun, H., & Yoon, J.-W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8280 · Cited by 96
Amin, M. A., Mansfield, P. J., Pákozdi, A., Campbell, P. L., Ahmed, S., Martinez, R. J., & Koch, A. E. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22705 · Cited by 96
IL-18 Enhances Collagen-Induced Arthritis by Recruiting Neutrophils Via TNF-α and Leukotriene B4
Cannetti, C. A., Leung, B. P. L., Culshaw, S., McInnes, I. B., Cunha, F. Q., & Liew, F. Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.1009 · Cited by 93
Onodera, S., Nishihira, J., Koyama, Y., Majima, T., Aoki, Y., Ichiyama, H., Ishibashi, T., & Minami, A. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20190 · Cited by 92
Local expression of interleukin‐27 ameliorates collagen‐induced arthritis
Pickens, S. R., Chamberlain, N. D., Volin, M. V., Mandelin, A. M., Agrawal, H., Matsui, M., Yoshimoto, T., & Shahrara, S. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30324 · Cited by 91
Self-citationTak, P. P., Bacchi, M., & Bertolino, M. (2006) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03191127 · Cited by 87
Morel, J., Park, C. C., Kumar, P., & Koch, A. E. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780351 · Cited by 84
Madge, L. A., Kluger, M. S., Orange, J. S., & May, M. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3467 · Cited by 83
Abdulla, S. (1999) · Nature · doi:10.1038/news990624-7 · Cited by 82
Recent data on the role for angiogenesis in rheumatoid arthritis
Clavel, G., Bessis, N., & Boissier, M. (2003) · Joint Bone Spine · doi:10.1016/s1297-319x(03)00088-5 · Cited by 82
Isozaki, T., Arbab, A. S., Haas, C. S., Amin, M. A., Arendt, M. D., Koch, A. E., & Ruth, J. H. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37981 · Cited by 80
Autoimmune diseases: MIF as a therapeutic target
Greven, D., Leng, L., & Bucala, R. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903551304 · Cited by 80
Junctional Adhesion Molecule-C Is a Soluble Mediator of Angiogenesis
Rabquer, B. J., Amin, M. A., Teegala, N., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000556 · Cited by 78
Role of the CCL21 and CCR7 pathways in rheumatoid arthritis angiogenesis
Pickens, S. R., Chamberlain, N. D., Volin, M. V., Pope, R. M., Talarico, N. E., Mandelin, A. M., & Shahrara, S. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34452 · Cited by 78
Self-citationPodar, K., Zimmerhackl, A., Fulciniti, M., Tonon, G., Hainz, U., Tai, Y., Vallet, S., Halama, N., Jäger, D., Olson, D. L., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08864.x · Cited by 76
Shahrara, S., Amin, M. A., Woods, J. M., Haines, G. K., & Koch, A. E. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11344 · Cited by 74
Self-citationKayakabe, K., Kuroiwa, T., Sakurai, N., Ikeuchi, H., Kadiombo, A. T., Sakairi, T., Matsumoto, T., Maeshima, A., Hiromura, K., & Nojima, Y. (2012) · Lara D. Veeken · doi:10.1093/rheumatology/kes093 · Cited by 74
Drug evaluation: apratastat, a novel TACE/MMP inhibitor for rheumatoid arthritis.
Thabet, M. M., & Huizinga, T. W. J. (2006) · PubMed · Cited by 72
Angiogenesis as Risk Factor for Plaque Vulnerability
Stefano, R. D., Felice, F., & Balbarini, A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787846892 · Cited by 72
IL‐15 mediates antigen‐induced neutrophil migration by triggering IL‐18 production
Verri, W. A., Jr., Cunha, T. M., Ferreira, S. H., Wei, X., Leung, B. P. L., Fraser, A. R., McInnes, I. B., Liew, F. Y., & Cunha, F. Q. (2007) · European Journal of Immunology · doi:10.1002/eji.200737488 · Cited by 71
Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis.
Ghanem, I., Riveiro, M. E., Paradis, V., Faivre, S. J., de Parga, P. V., & Raymond, É. (2014) · PubMed Central · Cited by 70
Interleukin 18 induces angiogenesis in vitro and in vivo via Src and Jnk kinases
Amin, M. A., Rabquer, B. J., Mansfield, P. J., Ruth, J. H., Marotte, H., Haas, C. S., Reamer, E. N., & Koch, A. E. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.127241 · Cited by 70
Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting
Veale, D. J., & Fearon, U. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.05.004 · Cited by 68
The role of angiogenesis in the pathogenesis of psoriasis
Chua, R. A., & Arbiser, J. L. (2009) · Autoimmunity · doi:10.1080/08916930903002461 · Cited by 65
Are fibroblasts involved in joint destruction?
Pap, T., Meinecke, I., Müller-Ladner, U., & Gay, S. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.042424 · Cited by 64
Chen, Z., Kim, S.-J., Essani, A. B., Volin, M. V., Vila, O. M., Swedler, W. I., Arami, S., Volkov, S., Sardin, L. V., Sweiss, N., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204530 · Cited by 62
Self-citationInterferon-γ Stimulates the Expression of CX3CL1/Fractalkine in Cultured Human Endothelial Cells
Imaizumi, T., Matsumiya, T., Fujimoto, K., Okamoto, K., Cui, X., Ohtaki, U., Yoshida, H., & Satoh, K. (2000) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.192.127 · Cited by 58
Santos, L. L., Dacumos, A., Yamana, J., Sharma, L., & Morand, E. F. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03639.x · Cited by 57
SDF-1 signaling: a promising target in rheumatic diseases
Villalvilla, A., Gómez, R., Roman‐Blas, J. A., Largo, R., & Herrero‐Beaumont, G. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.930440 · Cited by 56
Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization
Pickens, S. R., Chamberlain, N. D., Volin, M. V., Gonzalez, M. H., Pope, R. M., Mandelin, A. M., Kolls, J. K., & Shahrara, S. (2011) · Angiogenesis · doi:10.1007/s10456-011-9227-z · Cited by 54
Self-citationBuilding blood vessels in development and disease
Kushner, E. J., & Bautch, V. L. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328360614b · Cited by 50
Therapeutic opportunities in fibroblasts in inflammatory arthritis
Niedermeier, M., Pap, T., & Korb, A. (2010) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2010.02.002 · Cited by 48
Strunk, J., Bundke, E., & Lange, U. (2005) · Rheumatology International · doi:10.1007/s00296-005-0619-5 · Cited by 45
Endothelial Cells in Inflammation and Angiogenesis
Szekanecz, Z., & Koch, A. E. (2005) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010054022187 · Cited by 42
Kim, S.-J., Chen, Z., Chamberlain, N. D., Volin, M. V., Swedler, W. I., Volkov, S., Sweiss, N., & Shahrara, S. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37992 · Cited by 41
Self-citationExpression and function of junctional adhesion molecule-C in human and experimental arthritis
Palmer, G., Busso, N., Aurrand‐Lions, M., Talabot‐Ayer, D., Chobaz-Péclat, V., Zimmerli, C., Hammel, P., Imhof, B. A., & Gabay, C. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2223 · Cited by 40
Targeting cell migration in rheumatoid arthritis
Asquith, D. L., Bryce, S. A., & Nibbs, R. J. B. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000150 · Cited by 37
Weeraratne, D. K., Lofgren, J. A., Dinnogen, S., Swanson, S. J., & Zhong, Z. D. (2013) · Journal of Immunological Methods · doi:10.1016/j.jim.2013.07.010 · Cited by 37
Ruth, J. H., Park, C. C., Amin, M. A., Lesch, C. A., Marotte, H., Shahrara, S., & Koch, A. E. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3055 · Cited by 37
Self-citationPark, Y., Kim, J., Park, J., Choi, J., Kim, W., & Cho, C. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38352 · Cited by 35
Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium
Rabquer, B. J., Pákozdi, A., Michel, J. E., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23867 · Cited by 35
Current Clinical Indications for Plerixafor
Früehauf, S. (2013) · Transfusion Medicine and Hemotherapy · doi:10.1159/000354229 · Cited by 33
Suppression of endothelial cell activity by inhibition of TNFα
Shu, Q., Amin, M. A., Ruth, J. H., Campbell, P. L., & Koch, A. E. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3812 · Cited by 32
Leinster, D. A., Colom, B., Whiteford, J. R., Ennis, D. P., Lockley, M., McNeish, I. A., Aurrand‐Lions, M., Chavakis, T., Imhof, B. A., Balkwill, F. R., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-230441 · Cited by 31
Expression of interleukin-18 receptor in fibroblast-like synoviocytes
Möller, B., Kessler, U., Rehart, S., Kalina, U., Ottmann, O. G., Kaltwasser, J. P., Hoelzer, D. F., & Kukoc-Zivojnov, N. (2001) · Arthritis Research & Therapy · doi:10.1186/ar390 · Cited by 27
Singh, A., Leng, L., Fan, J., Gajda, M. R., Bräuer, R., Fingerle‐Rowson, G., Bucala, R., & Illges, H. (2013) · Rheumatology International · doi:10.1007/s00296-013-2713-4 · Cited by 27
Computational gene network analysis reveals TNF-induced angiogenesis
Ogami, K., Yamaguchi, R., Imoto, S., Tamada, Y., Araki, H., Print, C. G., & Miyano, S. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-s2-s12 · Cited by 25
Hah, Y., Koh, Y. J., Lim, H. S., Kim, H. O., Cheon, Y., Noh, H. S., Jang, K. Y., Lee, S. Y., Lee, G. M., Koh, G. Y., et al. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4265 · Cited by 24
Putative effects of potentially anti-angiogenic drugs in rheumatic diseases
Maruotti, N., Cantatore, F. P., & Ribatti, D. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1605-6 · Cited by 16
Jones, R. (2000) · PubMed · Cited by 14
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
Gergely, P., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., Banki, K., Phillips, P. E., & Perl, A. (2002) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200201)46:1 · Cited by 5
Neidhart (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200012)43:12 · Cited by 1
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Management of Rheumatoid Arthritis: An Overview
Radu, A.-F., & Bungau, S. G. (2021) · Cells · doi:10.3390/cells10112857 · Cited by 1,089
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Lin, Y.-J., Anzaghe, M., & Schülke, S. (2020) · Cells · doi:10.3390/cells9040880 · Cited by 932
The role of HIF in immunity and inflammation
McGettrick, A. F., & O’Neill, L. A. J. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.002 · Cited by 768
Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments
Zuo, L., Prather, E. R., Stetskiv, M., Garrison, D. E., Meade, J. R., Peace, T. I., & Zhou, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184472 · Cited by 539
Pathological angiogenesis: mechanisms and therapeutic strategies
Dudley, A. C., & Griffioen, A. W. (2023) · Angiogenesis · doi:10.1007/s10456-023-09876-7 · Cited by 495
Metadata
- Authors
- Elshabrawy, H. A., Chen, Z., Volin, M. V., Ravella, S., Virupannavar, S., & Shahrara, S.
- Venue
- Angiogenesis
- Published
- 2015-07-22
- Volume
- 18
- Issue
- 4
- Pages
- 433-448
- ISSN
- 0969-6970 (ISSN-L)
- 1573-7209
- OpenAlex
- W972043883
- Cited by
- 533
- References
- 173
- FWCI
- 19.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.